3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
5
Lung Neoplasms
3
Breast Neoplasms
3
Pancreatic Neoplasms
2
Multiple Myeloma
2
Gastrointestinal Neoplasms
2
Uterine Cervical Neoplasms
1
Support of the Family as a Caregiving System
1
Stomach Neoplasms
1
Quality of Life
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Pain
1
Otorhinolaryngologic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Mixed Dementias
1
Mesothelioma, Malignant
1
Meningeal Carcinomatosis
1
Maxillary Sinus Neoplasms
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Follicular
1
Lymphoma
1
Localized Head and Neck Carcinoma
1
Lewy Body Disease
1
Interventions
Paclitaxel
114
Carboplatin
114
Cisplatin
45
Topotecan
43
Gemcitabine
31
Cyclophosphamide
31
Docetaxel
28
liposomal doxorubicin
27
Bevacizumab
27
Filgrastim
20
pembrolizumab
19
Peripheral Blood Stem Cell Transplantation
18
Taxes
15
Drug Therapy
15
sargramostim
12
Hyperthermic Intraperitoneal Chemotherapy
12
olaparib
11
Chemotherapy, Adjuvant
10
Surgical Procedures, Operative
9
Etoposide
9
oregovomab
8
mirvetuximab soravtansine
8
Nivolumab
8
Amifostine
8
Therapeutics
7
Melphalan
7
Erlotinib Hydrochloride
7
rucaparib
6
aldesleukin
6
Oxaliplatin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Carcinoma, Ovarian Epithelial
×
Referral and Consultation
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled